Hangzhou Grascent Co., Ltd.

301688 · SHE · Basic Materials / Specialty Chemicals

33.16CNY-1.48 (-4.27%)

Price History

Full chart

Market Stats

Previous Close34.64

Open34.75

Day Range32.99 – 35.01

52-Week Range29.50 – 72.00

Volume2.97M

Market Cap4.80B

P/E (TTM)21.18

Forward P/E0.00

EPS1.70

Dividend Yield0.00%

50-Day Avg37.23

200-Day Avg37.23

About

Hangzhou Grascent Co., Ltd. manufactures and sells cedarwood oil derivatives, turpentine oil derivatives, and other products in China. The company's products include rose ketone, allyl cyclohexyl propionate, Myrac Aldehyde, Damascenone Total, Muscosandrol, alpha-Damascone, Dimethyl Heptanol, Floramelon, MegaSantol, linalool oxides, and other chemical derivatives. The company's products are used as cosmetic ingredients for the manufacturing of cosmetic and personal care formulas for bath/shower, color, cosmetics, hair care, oral care, and skin care. The company exports its products to European and American markets. The company was formerly known as Hangzhou Aroma Chemical Company and changed its name to Hangzhou Grascent Co., Ltd. in April 2011. The company was founded in 1999 and is based in Jiande, China.

Company Details

SectorBasic Materials
IndustrySpecialty Chemicals
CEOMr. Huangyu Jiang
Employees545
HeadquartersMamu-Nanfeng High-tech Industrial zone, Jiande, China, 311604, China
Websitehttps://www.hangzhougrascent.com

Leadership

Mr. Huangyu JiangDeputy GM, Board Secretary & Employee Director · b. 1982
Ms. Dan WuChairman's Assistant · b. 1986
Mr. Chao ZhuAssistant General Manager · b. 1982
Mr. Li Ren WangGeneral Manager · b. 1967
Ms. Dong Xia ChenVice Chairman & Deputy GM · b. 1965
Ms. Zhao Juan WuChief Financial Officer · b. 1982
Gui Xia ChenSales & Marketing Manager
Mr. Jian Liang HuDeputy GM and Head of R&D · b. 1973
Mr. Chuan Ming LinDeputy GM & Chief Engineer · b. 1979
Mr. Jia De ChenInternal Audit Manager & Director · b. 1952

Financials

Income Statement

Currency: CNY	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	631.28M	734.76M	960.58M	1.07B
Growth (%)	-	+16.39%	+30.73%	+11.90%
Cost of Revenue	484.59M	542.01M	675.28M	733.51M
Gross Profit	146.70M	192.75M	285.30M	341.40M
Gross Margin	23.24%	26.23%	29.70%	31.76%
Operating Expense	52.19M	69.30M	91.67M	103.23M
Operating Income	94.51M	123.45M	193.64M	238.17M
Operating Margin	14.97%	16.80%	20.16%	22.16%
EBITDA	183.85M	218.52M	307.83M	334.87M
EBITDA Margin	29.12%	29.74%	32.05%	31.15%
Net Income	68.14M	92.92M	150.45M	178.96M
Net Income Margin	10.79%	12.65%	15.66%	16.65%
R&D	14.76M	18.52M	26.18M	37.26M
R&D as % of Total Revenue	2.34%	2.52%	2.73%	3.47%
Interest Expense	68.27M	72.01M	74.99M	53.17M
Interest Expense % of Total Revenue	10.81%	9.80%	7.81%	4.95%

Balance Sheet

Currency: CNY	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	1.19B	1.43B	1.65B	1.78B
Total Liabilities	786.60M	938.92M	1.08B	1.03B
Total Equity	405.06M	494.96M	566.08M	748.68M
Cash	29.83M	22.75M	54.13M	71.84M
Net Debt	468.36M	565.08M	635.43M	637.01M

Cash Flow

Currency: CNY	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	120.54M	140.54M	206.08M	158.52M
Capital Expenditure	254.61M	244.56M	197.76M	88.42M
Free Cash Flow	-134.07M	-104.02M	8.32M	70.10M
Dividends Paid	100.46M	28.44M	108.96M	27.08M
FCF to OCF	-111.22%	-74.02%	4.04%	44.22%
Dividend Paid to FCF	-74.93%	-27.34%	1309.55%	38.63%

Earnings

Report Date	Sep 30, 2026
EPS Estimate	-
EPS Actual	0.30
Surprise	-
Timing	-

Key Statistics & Ratios

Market Cap4.80B

Enterprise Value4.77B

Trailing P/E21.18

Forward P/E0.00

Price / Sales4.23

Price / Book2.89

EPS1.70

Book Value8.51

Revenue (TTM)1.14B

Gross Profit (TTM)360.50M

EBITDA320.09M

Profit Margin16.11%

Operating Margin22.40%

Return on Equity0.00%

Return on Assets0.00%

Shares Outstanding133.33M

Shares Float26.64M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%